X0306 4 2021-09-15 false 0001770121 Sana Biotechnology, Inc. SANA 0001616640 AGARWAL SUNIL C/O SANA BIOTECHNOLOGY, INC. 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 false true false false EVP, Head of Development & CMO Common Stock 2021-09-15 4 S false 58373.00 26.0695 D 1551627.00 D Common Stock 2021-09-16 4 S false 1627.00 26.00 D 1550000.00 D The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 5, 2021. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.00 to $26.225, inclusive. The reporting person undertakes to provide to Sana Biotechnology, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. /s/ James J. MacDonald, Attorney-in-Fact for Sunil Agarwal 2021-09-17